Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: J Pain. 2012 Jan 29;13(3):266–275. doi: 10.1016/j.jpain.2011.11.004

Table 2.

Prevalence (%) of concurrent alcohol and sedative use by categories of demographic, clinical and opioid-related variables—stratified by history of substance use disorder (SUD).

Variables Concurrent Alcohol Use (%) Concurrent Sedative Use (%)
No SUD SUD No SUD SUD
Overall 12.0 13.2 28.7 38.9
Age
21-44 14.3 17.6 35.0 50.3*
45-64 11.3 13.2 28.8 40.2
65+ 12.1 9.4 24.3 24.6*
Sex
Female 9.3* 5.9*** 32.4** 48.4**
Male 17.8 20.3 20.8 29.6
Depression
No 16.1* 12.8 20.8** 26.4**
Yes 8.8 13.4 34.9 44.3
Average daily opioid dose
1- < 20 mg. MED 15.4 10.6 20.9** 17.3**
20- < 50 mg. MED 12.4 15.4 26.5 41.1
50- < 120 mg. MED 10.2 14.7 36.0 40.8
120+ mg. MED 5.5 10.3 41.6 47.9
# of pain conditions for which opioids are taken
One 11.1 14.9 21.7** 33.5
Two or more 12.5 12.4 33.0 41.5
Average pain intensity in last 3 months (0-10)
0-4 10.5 22.8* 25.5 33.4
5-6 12.2 13.0 28.1 40.9
7+ 11.5 7.6 31.8 40.6

Abbreviations: MED, morphine equivalent dose NOTE: Significance tests compare categories of variables within a column, not across columns.

*

Significant at P = .05

**

Significant at P = .01

***

Significant at P < .0001